Rohan Palanki

1.1k total citations
22 papers, 538 citations indexed

About

Rohan Palanki is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Rohan Palanki has authored 22 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Immunology. Recurrent topics in Rohan Palanki's work include RNA Interference and Gene Delivery (13 papers), Virus-based gene therapy research (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Rohan Palanki is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Virus-based gene therapy research (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Rohan Palanki collaborates with scholars based in United States, China and Croatia. Rohan Palanki's co-authors include Michael J. Mitchell, William H. Peranteau, Kelsey L. Swingle, Emily L. Han, Alex G. Hamilton, Brian P. Landry, Jeffrey J. Tabor, Lucas A. Hartsough, Marshall S. Padilla and Kaitlin Mrksich and has published in prestigious journals such as Nature, Cell and Journal of the American Chemical Society.

In The Last Decade

Rohan Palanki

20 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rohan Palanki United States 13 368 68 68 61 59 22 538
Isha Khurana India 9 297 0.8× 70 1.0× 125 1.8× 48 0.8× 78 1.3× 13 643
Hua Xin China 11 504 1.4× 50 0.7× 61 0.9× 44 0.7× 23 0.4× 42 959
James Trevor Oswald Canada 8 266 0.7× 51 0.8× 72 1.1× 54 0.9× 73 1.2× 8 390
Anindit Mukherjee United States 9 303 0.8× 27 0.4× 103 1.5× 36 0.6× 86 1.5× 11 465
Atieh Hashemi Iran 13 311 0.8× 48 0.7× 64 0.9× 63 1.0× 65 1.1× 44 473
Xinyan Hao China 10 225 0.6× 27 0.4× 106 1.6× 123 2.0× 54 0.9× 19 468
Mehdi Forouzandeh Iran 14 518 1.4× 49 0.7× 132 1.9× 87 1.4× 19 0.3× 29 817
Qiumei Wu China 8 164 0.4× 36 0.5× 104 1.5× 28 0.5× 27 0.5× 12 434

Countries citing papers authored by Rohan Palanki

Since Specialization
Citations

This map shows the geographic impact of Rohan Palanki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohan Palanki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohan Palanki more than expected).

Fields of papers citing papers by Rohan Palanki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohan Palanki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohan Palanki. The network helps show where Rohan Palanki may publish in the future.

Co-authorship network of co-authors of Rohan Palanki

This figure shows the co-authorship network connecting the top 25 collaborators of Rohan Palanki. A scholar is included among the top collaborators of Rohan Palanki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohan Palanki. Rohan Palanki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palanki, Rohan, et al.. (2025). Nanoparticle‐Based Tolerogenic Vaccines: Next‐Generation Strategies for Autoimmune and Allergic Disease Therapies. Angewandte Chemie International Edition. 65(6). e24097–e24097.
2.
Gong, Ningqiang, Dongyoon Kim, Mohamad‐Gabriel Alameh, et al.. (2025). Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity. Nature Biomedical Engineering. 9(12). 2181–2195. 2 indexed citations
3.
Haley, Rebecca M., Marshall S. Padilla, Rakan El‐Mayta, et al.. (2025). Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets. ACS Nano. 19(14). 13790–13804. 6 indexed citations
4.
Wu, Fan, et al.. (2025). Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components. Small Methods. 10(2). e2401632–e2401632. 5 indexed citations
5.
Xue, Lulu, Xinhong Xiong, Gan Zhao, et al.. (2025). Multiarm-Assisted Design of Dendron-like Degradable Ionizable Lipids Facilitates Systemic mRNA Delivery to the Spleen. Journal of the American Chemical Society. 147(2). 1542–1552. 10 indexed citations
6.
Safford, Hannah C., Rohan Palanki, Melgious Jin Yan Ang, & Michael J. Mitchell. (2025). Emerging Nucleic Acid Cargos for Next-Generation RNA Vaccines and Therapeutics. Bioconjugate Chemistry. 36(11). 2317–2323.
7.
Han, Emily L., Marshall S. Padilla, Rohan Palanki, et al.. (2024). Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing. Nano Letters. 24(5). 1477–1486. 42 indexed citations
8.
Han, Emily L., Kelsey L. Swingle, Alex G. Hamilton, et al.. (2024). Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain. Nano Letters. 25(2). 800–810. 41 indexed citations
9.
Han, Xuexiang, Junchao Xu, Ying Xu, et al.. (2024). In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors. Nature Communications. 15(1). 1762–1762. 41 indexed citations
10.
Han, Xuexiang, Mohamad‐Gabriel Alameh, Ying Xu, et al.. (2024). Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution. Nature Biomedical Engineering. 8(11). 1412–1424. 22 indexed citations
11.
Swingle, Kelsey L., Alex G. Hamilton, Hannah C. Safford, et al.. (2024). Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia. Nature. 637(8045). 412–421. 39 indexed citations
12.
Palanki, Rohan, Emily L. Han, Kelsey L. Swingle, et al.. (2024). Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing. Lab on a Chip. 24(16). 3790–3801. 13 indexed citations
13.
Palanki, Rohan, et al.. (2024). OLAH connects fatty acid metabolism to the severity of respiratory viral disease. Cell. 187(17). 4549–4551. 2 indexed citations
14.
Thatte, Ajay S., Alex G. Hamilton, Alvin J. Mukalel, et al.. (2023). mRNA Lipid Nanoparticles for Ex Vivo Engineering of Immunosuppressive T Cells for Autoimmunity Therapies. Nano Letters. 23(22). 10179–10188. 25 indexed citations
15.
Costa, Pedro Augusto Carvalho, Walison N. Silva, Pedro Henrique Dias Moura Prazeres, et al.. (2023). siRNA lipid nanoparticles for CXCL12 silencing modulate brain immune response during Zika infection. Biomedicine & Pharmacotherapy. 170. 115981–115981. 5 indexed citations
16.
Swingle, Kelsey L., Margaret M. Billingsley, Sourav K. Bose, et al.. (2021). Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery. Journal of Controlled Release. 341. 616–633. 51 indexed citations
17.
Landry, Brian P., et al.. (2018). Phosphatase activity tunes two-component system sensor detection threshold. Nature Communications. 9(1). 1433–1433. 72 indexed citations
18.
Palanki, Rohan, et al.. (2015). Design and Evaluation of a Low-cost Piezoelectric Device for Remote Diagnosis of Respiratory Diseases. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Palanki, Rohan, Sumit Arora, Nikhil Tyagi, et al.. (2015). Size is an essential parameter in governing the UVB-protective efficacy of silver nanoparticles in human keratinocytes. BMC Cancer. 15(1). 636–636. 20 indexed citations
20.
Arora, Sumit, Nikhil Tyagi, Arun Bhardwaj, et al.. (2015). Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis. Nanomedicine Nanotechnology Biology and Medicine. 11(5). 1265–1275. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026